Preconditioning With High Mobility Group Box 1 (HMGB1) Induces Lipoteichoic Acid (LTA) Tolerance

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of immunotherapy

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CJI.0b013e3181dcd111PMID 20664360PMCID PMC2954270
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development of endotoxin tolerance in humans in vivo

  2009cited by this paper
• HMGB1 IS MARKEDLY ELEVATED WITHIN 6 HOURS OF MECHANICAL TRAUMA IN HUMANS

  2009cited by this paper
• The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation

  2009cited by this paper
• Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance

  2008cited by this paper
• The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid1

  2007cited by this paper
• DAMPs, PAMPs and alarmins: all we need to know about danger

  2007cited by this paper
• Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis*

  2007cited by this paper
• Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin).

  2007cited by this paper
• Role of HMGB1 in apoptosis-mediated sepsis lethality.

  2006cited by this paper
• High mobility group box 1 protein interacts with multiple Toll-like receptors.

  2006cited by this paper
• The extracellular release of HMGB1 during apoptotic cell death.

  2006cited by this paper
• Role of HMGB1 in apoptosis-mediated sepsis lethality

  2006cited by this paper
• HMGB1 is secreted by immunostimulated enterocytes and contributes to cytomix-induced hyperpermeability of Caco-2 monolayers.

  2006cited by this paper
• HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2

  2006cited by this paper
• NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1.

  2005cited by this paper
• Lipoteichoic acid induces nuclear factor‐κB activation and nitric oxide synthase expression via phosphatidylinositol 3‐kinase, Akt, and p38 MAPK in RAW 264.7 macrophages

  2005influential reference
• Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells

  2005cited by this paper
• RAGE is the Major Receptor for the Proinflammatory Activity of HMGB1 in Rodent Macrophages

  2005cited by this paper
• Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*

  2005cited by this paper
• Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1

  2005cited by this paper
• Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein*

  2004cited by this paper
• HMGB1 is an endogenous immune adjuvant released by necrotic cells

  2004cited by this paper
• Native Versus Recombinant High-Mobility Group B1 Proteins: Functional Activity In Vitro

  2004cited by this paper
• Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

  2004cited by this paper
• High Mobility Group Box Protein 1: An Endogenous Signal for Dendritic Cell Maturation and Th1 Polarization

  2004cited by this paper
• Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High‐Mobility Group Box Chromosomal Protein 1

  2004cited by this paper
• Regulation of monocyte migration by amphoterin (HMGB1).

  2004cited by this paper
• A Green Tea-Derived Polyphenol, Epigallocatechin-3-Gallate, Inhibits IκB Kinase Activation and IL-8 Gene Expression in Respiratory Epithelium

  2004cited by this paper
• Extracellular role of HMGB1 in inflammation and sepsis

  2004cited by this paper
• Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

  2004cited by this paper
• Tolerance Induced by the Lipopeptide Pam3Cys Is Due to Ablation of IL-1R-Associated Kinase-11

  2004cited by this paper
• Endotoxin tolerance: is there a clinical relevance?

  2003cited by this paper
• HMGB1 as a DNA‐binding cytokine

  2002cited by this paper
• Lipopolysaccharide- and Lipoteichoic Acid-Induced Tolerance and Cross-Tolerance: Distinct Alterations in IL-1 Receptor-Associated Kinase1

  2002influential reference
• Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

  2002cited by this paper
• Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.

  2002cited by this paper
• Endotoxin tolerance: A review

  2002cited by this paper
• The High Mobility Group (Hmg) Boxes of the Nuclear Protein Hmg1 Induce Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells

  2001cited by this paper
• Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators1

  2001cited by this paper
• HMGB1 as a late mediator of lethal systemic inflammation.

  2001cited by this paper
• Lipoteichoic acid induces delayed protection in the rat heart: A comparison with endotoxin.

  2000cited by this paper
• High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

  2000cited by this paper
• HMG-1 as a mediator of acute lung inflammation.

  2000cited by this paper
• Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1

  2000influential reference
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.

  1999cited by this paper
• Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins

  1999cited by this paper
• Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

  1999influential reference
• Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers.

  1994cited by this paper
• Dysregulation of in vitro cytokine production by monocytes during sepsis.

  1991cited by this paper
• Physiology of lipoteichoic acids in bacteria.

  1988cited by this paper
• Comparison of Bone Marrow Progenitors Responsive to Granulocyte‐Macrophage Colony Stimulating Factor and Macrophage Colony Stimulating Factor‐1

  1988cited by this paper
• The nature of endotoxin tolerance.

  1975cited by this paper

• Damage-associated molecular patterns (DAMPs) in diseases: implications for therapy

  2025cites this paper
• The immune suppressive properties of damage associated molecular patterns in the setting of sterile traumatic injury

  2023cites this paper
• HMGB1/TLR4 Signaling Affects Regulatory T Cells in Acute Lung Injury

  2021cites this paper
• Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review

  2021cites this paper
• Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis

  2020cites this paper
• Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?

  2020cites this paper
• Toxic effects of perinatal maternal exposure to nonylphenol on lung inflammation in male offspring rats.

  2020cites this paper
• Targeting Inflammation Driven by HMGB1

  2020cites this paper
• Severe Trauma and Sepsis

  2019cites this paper
• Modulation of HMGB1 Release for Treating Lethal Infection and Injury

  2019cites this paper
• Sera from Septic Patients Contain the Inhibiting Activity of the Extracellular ATP-Dependent Inflammasome Pathway.

  2018cites this paper
• The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas.

  2017cites this paper
• The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas

  2017cites this paper
• HMGB1 in health and disease.

  2014cites this paper
• Targeting HMGB1 in the treatment of sepsis

  2014cites this paper
• Poly(ADP-Ribose) Polymerase 1-Sirtuin 1 Functional Interplay Regulates LPS-Mediated High Mobility Group Box 1 Secretion

  2014cites this paper
• The Role of High Mobility Group Box 1 in Innate Immunity

  2014cites this paper
• Cellular signalling of the receptor for advanced glycation end products (RAGE).

  2013cites this paper
• Attenuation of Myocardial Injury by HMGB1 Blockade during Ischemia/Reperfusion Is Toll-Like Receptor 2-Dependent

  2013cites this paper
• Endogenous HMGB1 is required in endotoxin tolerance.

  2013influential citation
• [New aspects of sepsis pathophysiology in critically ill].

  2012cites this paper
• PI3K/Akt signaling pathway involved in cardioprotection of preconditioning with high mobility group box 1 protein during myocardial ischemia and reperfusion.

  2011cites this paper